Barclays
FBLG icon

Barclays’s FibroBiologics FBLG Stock Holding History

Barclays’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$38 Sell
29
-7,214
-100% -$8.41K ﹤0.01% 5092
2026
Q2 		$6.86K Buy
+7,243
New +$8.41K ﹤0.01% 4746
2026
Q1 		– Hold
0
– – – 5515
2025
Q4 		– Hold
0
– – – 5771
2025
Q3 		– Hold
0
– – – 5454
2025
Q2 		– Sell
-1,486
Closed -$26.8K – 5207
2025
Q1 		$26.7K Sell
1,486
-679
-31% -$19.4K ﹤0.01% 4747
2024
Q4 		$86.6K Buy
2,165
+167
+8% +$8.96K ﹤0.01% 4629
2024
Q3 		$123K Buy
1,998
+1,567
+364% +$104K ﹤0.01% 4514
2024
Q2 		$43K Buy
+431
New +$82.2K ﹤0.01% 4261

Other funds holding FBLG

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Grove Bank & Trust
Grove Bank & Trust Miami, Florida $1.01B AUM 19.76% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Barclays's FBLG Position: Q3 2026 in Review

Barclays reduced its FibroBiologics (FBLG) stake by 100% in Q3 2026, selling an estimated $8.41K and leaving 29 shares worth $38. The position accounts for ﹤0.01% of the portfolio, ranked #5092.

Barclays first reported a position in FBLG in Q2 2024 and has held it in 6 quarters since. The position peaked at $123K in Q3 2024. 9 funds tracked by Wall St. Rank hold FBLG as of Q3 2026.

  • Barclays held 29 shares of FibroBiologics worth $38 as of Q3 2026.
  • Barclays sold 7,214 FibroBiologics shares in Q3 2026, an estimated $8.41K.
  • FibroBiologics made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #5092 holding.
  • Barclays first reported a position in FibroBiologics in Q2 2024 and has held it in 6 quarters since.
  • Barclays's FibroBiologics position peaked at $123K in Q3 2024.
  • 9 funds tracked by Wall St. Rank held FibroBiologics as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.